文献速递神经肿瘤

基于手术紧迫性的经蝶垂体手术患者术前分层

Preoperative Stratification of Transsphenoidal Pituitary Surgery Patients Based on Surgical Urgency.
PubMed 文献 · Neurosurgery · 2017-01-01

国际专家小组回顾性分析布莱根妇女医院2008年1月至2015年11月因垂体疾病手术的患者,制定四组手术紧迫性风险分层方案并分配治疗时间线:A组紧急-立即、B组尽快1至2周内、C组不久3个月内、D组择期。472例垂体腺瘤患者中A组6.8%、B组30.1%、C组31.1%、D组32.0%。

要点

  • 专家小组制定四组手术紧迫性分层:A紧急-立即、B尽快1至2周内、C不久3个月内、D择期。
  • 472例垂体腺瘤患者中A组占6.8%、B组占30.1%、C组占31.1%、D组占32.0%。
  • 作者认为该分层方案可能作为平台优化最高风险患者的诊疗流程。

核心结论

  • 作者开发了风险分层方案,可能作为平台优化最高风险患者的诊疗流程,专家意见为未来风险优先排序研究提供基础。

研究设计与样本

  • 国际专家小组由参与鞍区疾病诊断与治疗的内分泌科医生和神经外科医生组成,回顾性审查个人经验,包括布莱根妇女医院2008年1月至2015年11月因垂体相关疾病手术的患者队列。

主要发现

  • 识别出4组风险水平不同的手术候选者,并为其分配治疗时间线和不同鉴别诊断:A组紧急-立即;B组尽快-1至2周内开始治疗;C组不久-3个月内开始治疗;D组择期-有指征时尽快。
  • 布莱根妇女医院472例接受治疗的垂体腺瘤患者中,A组6.8%、B组30.1%、C组31.1%、D组32.0%。

关键数值与推荐

  • A组:紧急-立即。
  • B组:尽快-1至2周内开始治疗。
  • C组:不久-3个月内开始治疗。
  • D组:择期-有指征时尽快。

临床怎么用

  • 作者认为该风险分层方案可能作为平台优化最高风险患者的诊疗流程,专家意见为未来风险优先排序研究提供基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, there is no prioritization scale available to distinguish those patients with pituitary tumors who require urgent surgical intervention from those who are candidates for elective treatment. OBJECTIVE: To develop a classification system that can help primary care physicians, endocrinologists, neurosurgeons, ancillary support staff, and hospital administrators identify high-priority surgical candidates. METHODS: An expert international panel of clinicians consisting of endocrinologists and neurosurgeons who are involved in the diagnosis and management of sellar disease was convened. The panel retrospectively reviewed individual experiences, including a cohort of patients operated upon for pituitary related disease at the Brigham and Women's Hospital from January 2008 to November 2015. A risk stratification schema was developed to streamline patient care pathways. RESULTS: We identified 4 groups of surgical candidates with varying levels of risk, and then assigned treatment timelines and different differential diagnoses to each. The 4 groups were as follows: group A: urgent-immediate; group B: prompt-initiate treatment within 1 to 2 weeks; group C: soon-initiate treatment within 3 months; group D: elective-as soon as indicated. Among 472 patients treated at Brigham and Women's Hospital for pituitary adenomas, each was assigned to 1 of the 4 predetermined subgroups: group A, 6.8%; group B, 30.1%; group C, 31.1%; group D, 32.0%. CONCLUSIONS: We developed a risk stratification schema that may serve as a platform to streamline care to the patients at highest risk. The expert opinions presented provide a basis for future studies regarding the risk prioritization of patients.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Zaidi HA, Wang AJ, Cote DJ, et al. Preoperative Stratification of Transsphenoidal Pituitary Surgery Patients Based on Surgical Urgency. Neurosurgery. 2017. PMID: 28520927. doi:10.1093/neuros/nyx073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。